Daniel V. Paone

1.5k total citations
27 papers, 1.1k citations indexed

About

Daniel V. Paone is a scholar working on Organic Chemistry, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Daniel V. Paone has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Psychiatry and Mental health. Recurrent topics in Daniel V. Paone's work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (5 papers) and Synthetic Organic Chemistry Methods (4 papers). Daniel V. Paone is often cited by papers focused on Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (5 papers) and Synthetic Organic Chemistry Methods (4 papers). Daniel V. Paone collaborates with scholars based in United States, Canada and United Kingdom. Daniel V. Paone's co-authors include Larry E. Overman, Brian A. Stearns, Sergey A. Kozmin, Amos B. Smith, Christopher S. Burgey, Christopher M. Adams, James Z. Deng, Anthony W. Shaw, Theresa M. Williams and Stefanie A. Kane and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Daniel V. Paone

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel V. Paone United States 15 744 283 216 154 104 27 1.1k
Shawn P. Maddaford Canada 18 563 0.8× 253 0.9× 103 0.5× 59 0.4× 53 0.5× 34 915
Gerard M.P. Giblin United Kingdom 21 527 0.7× 393 1.4× 63 0.3× 239 1.6× 65 0.6× 54 1.2k
Andrew P. Degnan United States 13 304 0.4× 185 0.7× 45 0.2× 103 0.7× 28 0.3× 23 558
Yao‐Chang Xu United States 13 365 0.5× 161 0.6× 156 0.7× 48 0.3× 109 1.0× 30 705
E. W. COLLINGTON United Kingdom 18 727 1.0× 324 1.1× 42 0.2× 70 0.5× 18 0.2× 47 1.0k
Elizabeth M. Beck United Kingdom 13 1.6k 2.1× 631 2.2× 29 0.1× 68 0.4× 18 0.2× 16 2.3k
Anjana Sinha United States 14 300 0.4× 391 1.4× 208 1.0× 144 0.9× 9 0.1× 22 1.2k
Marta Costa Portugal 20 585 0.8× 325 1.1× 140 0.6× 46 0.3× 14 0.1× 48 1.2k
Alan D. Robertson United Kingdom 17 205 0.3× 405 1.4× 86 0.4× 138 0.9× 57 0.5× 31 887
Teodozyj Kolasa United States 19 538 0.7× 343 1.2× 69 0.3× 67 0.4× 11 0.1× 49 932

Countries citing papers authored by Daniel V. Paone

Since Specialization
Citations

This map shows the geographic impact of Daniel V. Paone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel V. Paone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel V. Paone more than expected).

Fields of papers citing papers by Daniel V. Paone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel V. Paone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel V. Paone. The network helps show where Daniel V. Paone may publish in the future.

Co-authorship network of co-authors of Daniel V. Paone

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel V. Paone. A scholar is included among the top collaborators of Daniel V. Paone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel V. Paone. Daniel V. Paone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckford, Paul D. W., Mohabir Ramjeesingh, Canhui Li, et al.. (2024). Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells. Respiratory Research. 25(1). 269–269. 2 indexed citations
2.
Macphee, Colin H., Xinzhong Dong, Peng Qi, et al.. (2024). Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders. Frontiers in Immunology. 15. 1433982–1433982. 8 indexed citations
3.
Paone, Daniel V., Kausik K. Nanda, Jing Li, et al.. (2022). Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 74. 128927–128927. 6 indexed citations
4.
Paone, Daniel V., Kausik K. Nanda, Jing Li, et al.. (2022). Lead Optimization of Cathepsin K Inhibitors for the Treatment of Osteoarthritis. SSRN Electronic Journal. 1 indexed citations
5.
Morriello, Gregori J., Michael P. Dwyer, Yili Chen, et al.. (2021). Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 44. 128082–128082. 1 indexed citations
6.
Béliveau, François, Sébastien P. Dion, Antoine Désilets, et al.. (2019). Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes. Cell chemical biology. 26(11). 1559–1572.e9. 25 indexed citations
7.
Stachel, Shawn J., Richard Berger, Daniel V. Paone, et al.. (2018). Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A Inhibitor. ACS Medicinal Chemistry Letters. 9(8). 815–820. 13 indexed citations
8.
Crowley, Brendan M., et al.. (2011). Expanding the scope of the Cu assisted Suzuki–Miyaura reaction. Tetrahedron Letters. 52(39). 5055–5059. 22 indexed citations
9.
Manley, Peter J., Daniel V. Paone, Christopher S. Burgey, et al.. (2011). Decahydroquinoline amides as highly selective CB2 agonists: Role of selectivity on in vivo efficacy in a rodent model of analgesia. Bioorganic & Medicinal Chemistry Letters. 21(8). 2359–2364. 15 indexed citations
10.
Paone, Daniel V., Diem N. Nguyen, Anthony W. Shaw, et al.. (2010). Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: Discovery of MK-2918. Bioorganic & Medicinal Chemistry Letters. 21(9). 2683–2686. 14 indexed citations
11.
Paone, Daniel V., et al.. (2009). Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review. Expert Opinion on Therapeutic Patents. 19(12). 1675–1713. 2 indexed citations
12.
Moore, Eric L., Christopher S. Burgey, Daniel V. Paone, et al.. (2008). Examining the binding properties of MK-0974: A CGRP receptor antagonist for the acute treatment of migraine. European Journal of Pharmacology. 602(2-3). 250–254. 21 indexed citations
13.
Paone, Daniel V. & Anthony W. Shaw. (2008). Synthesis of tri- and tetrasubstituted imidazoles. Tetrahedron Letters. 49(42). 6155–6159. 12 indexed citations
14.
Burgey, Christopher S., Daniel V. Paone, Anthony W. Shaw, et al.. (2008). Synthesis of the (3R,6S)-3-Amino-6-(2,3-difluorophenyl)azepan-2-one of Telcagepant (MK-0974), a Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine Headache. Organic Letters. 10(15). 3235–3238. 39 indexed citations
17.
Shaw, Anthony W., Daniel V. Paone, Diem N. Nguyen, et al.. (2007). Caprolactams as potent CGRP receptor antagonists for the treatment of migraine. Bioorganic & Medicinal Chemistry Letters. 17(17). 4795–4798. 31 indexed citations
18.
Nguyen, Diem N., Daniel V. Paone, Anthony W. Shaw, et al.. (2007). Calcitonin gene-related peptide (CGRP) receptor antagonists: Investigations of a pyridinone template. Bioorganic & Medicinal Chemistry Letters. 18(2). 755–758. 12 indexed citations
19.
Overman, Larry E. & Daniel V. Paone. (2001). Enantioselective Total Syntheses of Ditryptophenaline and ent-WIN 64821. Journal of the American Chemical Society. 123(38). 9465–9467. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026